Publications

The CNODES network of researchers, trainees, and analysts conduct studies using administrative healthcare data in response to queries from Canadian regulators. The results of these studies are published in open-access academic journals. CNODES also publishes a selection of its methodological advances, knowledge translation initiatives, and trainee projects.

Tascilar K, Azoulay A, Dell’Aniello S, Bartels DB, Suissa S. The use of telmisartan and the incidence of cancer. Am J Hyperten. 2016 Dec 1;29(12):1358-1365.

Platt RW. On Designs for Vaccine Surveillance. Drug Saf. 2016 Dec;39(12):1161-1162.

Schuster T, Lowe W, Platt RW. Propensity score model over-fitting leads to inflated variance of estimated odds ratios. Journal of Clinical Epidemiology. Journal of Clinical Epidemiology. J Clin Epidemiol. 2016 Dec;80:97-106.

Filion KB. Proton pump inhibitors and community acquired pneumonia: The observed link is probably due to protopathic bias and confounding by indication. BMJ 2016 Nov 17; 355:i6041. [Invited Editorial]

Tascilar K, Dell’Aniello S, Hudson M, Suissa S. Statins and Risk of Rheumatoid Arthritis – A Nested Case-Control Study. Arthritis Rheumatol. 2016 Nov;68(11):2603-2611.

Pang M, Schuster T, Filion KB, Schnitzer M, Eberg M, Platt RW. Effect Estimation in Point-exposure Studies with Binary Outcomes and High-dimensional Covariate Data – a comparison of Targeted Maximum Likelihood Estimation and Inverse Probability of Treatment Weighting. Int J Biostat. 2016 Nov 1;12(2).

Lian Y, Yin H, Pollak MN, Carrier S, Platt RW, Suissa S, Azoulay L. Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer. Eur Urol. 2016 Nov;70(5):808-815.

Hicks BM, Yin H, Yu OH, Pollak MN, Platt RW, Azoulay L. Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink. BMJ. 2016 Oct 20;355:i5340.

Faillie JL, Yu OH, Yin H, Hillaire-Buys D, Barkun A, Azoulay L. Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus. JAMA Intern Med. 2016 Oct 1;176(10):1474-1481.

Azoulay L, Filion B, Platt R, Dahl M, Dormuth C, Clemens K, Durand M, Hu N, Juurlink D, Paterson M, Targownik L, Turin T, Ernst P, CNODES Investigators. Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med. 2016 Oct 1;176(10):1464-1473.